Implantable ‘Living Pharmacy’ Produces Multiple Drugs Inside the Body
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
-
-
US measles cases top 1,500 as Texas outbreak grows
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
-
Biotechnology | Disease | FDA | Pharmaceutical | Rare Disease | Stem Cell
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
-
PTAB sides with Broad Institute over University of California on patent priority for use of CRISPR in eukaryotic cells
On Mar. 26, 2026, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (USPTO and PTAB,…
-
Largest Animal Health Emergency in U.S. History Continues as HPAI Devastates Indiana
On Mar. 26, 2026, Indiana’s poultry industry continues to face significant challenges as outbreaks of highly pathogenic avian…
-
Biotechnology | Disease | Neurology | Oncology | Pharmaceutical | Quantum
Merck to Acquire Terns Pharmaceuticals for $5.7 Billion, Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
-
‘Dead End’: Radical 20-Year Study Reveals Genetic Cloning Hits a Limit
On Mar. 25, 2026, researchers, led by scientists at the University of Yamanashi in Japan, cloned a single…
-
WHO Data Show Pertussis (Whooping Cough) Rising in Western Pacific and Europe
On Mar. 25, 2026, according to the latest data published by the World Health Organization (WHO), globally, 941,582…
-
Canine companions: revealing the genetic history of our first friends
On Mar. 24, 2026, researchers at the Francis Crick Institute report that the largest ancient DNA study of…
-
DNA in dirt is shaking up the study of human origins
On Mar. 24, 2026, a study published in Nature describes how researchers are pulling clues from genetic material…
-
UCB to Invest $2 Billion in Georgia, Establish First U.S. Manufacturing Facility
On Mar. 24, 2026, Governor Brian P. Kemp announced that global biopharmaceutical giant UCB, is planning a significant…
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
New enzyme atlas rewrites decades of biology research
On Mar. 23, 2026, The Walter and Eliza Hall Institute of Medical Research (WEHI) researchers have led a…
-
Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small‑Molecule API Manufacturing Capacity in Delaware
On Mar. 23, 2026, Wilmington PharmaTech, a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex…
-
Largest Animal Health Emergency in U.S. History Continues as HPAI Devastates Indiana
On Mar. 23, 2026, it was reported that since the beginning of March, highly pathogenic avian influenza has…
-
Novartis to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline for $3 Billion
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
-
NIH-awarded life scientist Shu Xiaokun abruptly shifts research from US to China
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
-
An analysis of 2.2 million people reveals shared and substance-specific genetic pathways for addiction risk
On Mar. 20, 2026, researchers of a Rutgers Health–led study led by Holly Poore, a faculty instructor of psychiatry…
-
Biotechnology | CDC | Infectious Disease | NIH | Vaccine | WHO
Danish university places hold on controversial U.S. CDC hepatitis B vaccine study in Guinea-Bissau
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves new higher-dose version of Wegovy shots
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
-
Biotechnology | CDC | Clinical Research | COVID-19 | Diagnostics | Genomics | Infectious Disease | Vaccine
CDC Reports Detection and Surveillance of New SARS-CoV-2 Variant BA.3.2
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
-
Astrobiologists Find All Five Nucleobases in Asteroid Ryugu
On Mar. 17, 2026, an international research team, including scientists from the Japan Agency for Marine-Earth Science and…
-
New Genetic Risk Score Better Predicts Diabetes, Obesity and Downstream Complications
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
-
China approves world’s first brain implant for commercialisation
On Mar. 14, 2026, China has approved its first brain implant designed to help people with paralysis regain…
-
Biotechnology | Disease | Imaging | Neurology | Therapeutics
RNA barcodes enable high-speed mapping of connections in the brain
On Mar. 13, 2026, a research team lead by Boxuan Zhao, a professor of cell and developmental biology…
-
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
-
GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
